Table 3.

Validation results

		N	Urine concentration	P
AAT	MCD	13 / 14	193.5 (102.49 –580.0) μg/ml	0.002
	FSGS	14 / 14	20.93 (10.45 –101.65) μg/ml
TF	MCD	12 / 14	653.63 (241.27 –1,348.38) μg/ml	0.002
	FSGS	14 / 14	129.96 (55.41 –267.10) μg/ml
HTN-3	MCD	5 / 14	0.35 (0.32 –0.48) μg/ml	0.03
	FSGS	3 / 14	0.22 (0.17 –0.23) μg/ml
MRPL17	MCD	12 / 14	242.98 (174.25 –534.75) pg/ml	0.001
	FSGS	14 / 14	111.86 (74.90 –154.78) pg/ml
PCNP	MCD	14 / 14	441.67 (152.50 –503.10) pg/ml	0.72
	FSGS	12 / 14	348.55 (216.25 –437.70) pg/ml
CALB2	MCD	14 / 14	3.52 (2.88 –4.40) pg/ml	0.002
	FSGS	14 / 14	6.98 (4.29 –8.65) pg/ml
CCNY	MCD	12 / 14	87.60 (83.40 –91.15) pg/ml	0.71
	FSGS	12 / 14	87.70 (84.30 –102.2) pg/ml
PTAFR	MCD	5 / 14	0.84 (0.46 –0.98) ng/ml	0.25
	FSGS	2 / 14	0.51 (0.36 –0.66) ng/ml

N represents the number of urine samples in which the proteins were detected by ELISA